Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production
about
Nitric oxide and peroxynitrite in health and diseaseAnti-cancer activity of nitrones in the Apc(Min/+) model of colorectal cancerSodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptorElevated incidence of polyp formation in APC(Min/⁺)Msh2⁻/⁻ mice is independent of nitric oxide-induced DNA mutationsInterplay between DNA repair and inflammation, and the link to cancerChemistry meets biology in colitis-associated carcinogenesisEffect of a nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on invasion of human colorectal cancer cell line SL-174T.Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthaseInducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis.The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.Spectroscopic microvascular blood detection from the endoscopically normal colonic mucosa: biomarker for neoplasia riskChronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulationVancomycin-sensitive bacteria trigger development of colitis-associated colon cancer by attracting neutrophils.Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient miceNitric oxide and cancer therapy: the emperor has NO clothesNitric oxide production upregulates Wnt/β-catenin signaling by inhibiting Dickkopf-1.Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitisiNOS-selective inhibitors for cancer prevention: promise and progress.Interleukin-22 drives nitric oxide-dependent DNA damage and dysplasia in a murine model of colitis-associated cancer.Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors.Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidenceSilibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway.Expression of inducible nitric oxide synthase is increased in rat Barrett's esophagus induced by duodenal contents refluxSilibinin prevents lung tumorigenesis in wild-type but not in iNOS-/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies.In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa.The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) miceIron: an emerging factor in colorectal carcinogenesis.Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation.A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer.
P2860
Q24645400-B103B659-A8CF-4D39-B4BA-53B984FE4271Q33514735-DD954C8B-E474-4B9B-B6AB-6201E493299EQ33884592-657268F2-BB04-4F68-9FAA-E4BF9F7007C6Q34761307-96A3F51D-3820-4F0F-ACC6-FA251E9451CFQ34989590-B7A193BE-52FD-45C3-8C94-A01EF7F23B3FQ35047726-59B47528-417D-49C7-BB0A-9BFB0AC7DF41Q35059579-04CCDF70-4EDD-489D-9294-06F4E91A8544Q35128757-D659C115-E015-4CAA-BAC3-B17EDAE6982FQ35596791-EC286F2A-D64A-413A-9044-A327788044BAQ35791288-C4B22727-976F-4476-834E-C0E3A48FADB5Q35819880-29FE5779-ACF7-41EE-B391-DD43B7CC15A2Q36118387-12A74917-8FDA-4A03-B88A-257D4F7FDA0BQ36212747-7988FDCF-9E84-469D-ACA0-EF0C2C8B4931Q36769027-0D821A08-E4F7-4C9D-BCDC-1D336657F975Q37079014-F35CDC43-E675-4FC4-9D78-19C8BC3A2156Q37195118-22A38CCB-C627-492F-9305-A85A1E4C3EE0Q37282036-25E09973-1714-495C-AB03-F83A77E035DDQ37365002-4C0606FC-35E6-4017-9BD5-F6AEB3134EDCQ38063301-186E47DF-23A6-449F-B2B0-913F00950329Q40332859-0D34F56A-8D95-481D-A7A3-30453CB1361DQ40651270-D35A934F-200C-41E1-A66E-E2ACC6FFDC28Q41854186-0387C25C-B4BD-4203-9561-1CB9FDE341C0Q41903138-AA747FEA-AD55-46EC-A881-9D365B6DBFD0Q42096807-040BC5ED-0E70-4EEB-B348-54788B649CC7Q42139184-5DF3B35E-AD13-47E0-B555-A5F55C86FE37Q42615418-B64FA8A4-AE63-49C4-89DA-94FC0600FB9DQ42738854-79CABC8E-800C-4E5A-8424-2FD4972447D9Q42922519-F9029033-2794-4802-90C1-00FCA0459E6CQ47720507-C9FD0602-C621-4CA7-A6C8-3A32EB006B42Q48252291-34467E5A-C0DB-419A-8142-20B19D84F2C7
P2860
Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production
description
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Dezember 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/12/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/12/01)
@nl
наукова стаття, опублікована в грудні 2001
@uk
مقالة علمية (نشرت في ديسمبر 2001)
@ar
name
Suppression of intestinal poly ...... biting nitric oxide production
@ast
Suppression of intestinal poly ...... biting nitric oxide production
@en
Suppression of intestinal poly ...... biting nitric oxide production
@nl
type
label
Suppression of intestinal poly ...... biting nitric oxide production
@ast
Suppression of intestinal poly ...... biting nitric oxide production
@en
Suppression of intestinal poly ...... biting nitric oxide production
@nl
prefLabel
Suppression of intestinal poly ...... biting nitric oxide production
@ast
Suppression of intestinal poly ...... biting nitric oxide production
@en
Suppression of intestinal poly ...... biting nitric oxide production
@nl
P3181
P1433
P1476
Suppression of intestinal poly ...... biting nitric oxide production
@en
P2093
P304
P3181
P407
P577
2001-12-01T00:00:00Z